ESC 365 - State of the Art - Drug-gene interaction paving the way to precision medicine

Back

ESC Premium Access

State of the Art - Drug-gene interaction paving the way to precision medicine

Session: What's new in genetics of heart disease

Topic: Basic Science

Speaker: Professor J. Hulot (Paris, FR)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Jean-Sebastien Hulot

PARCC INSERM U970 European Hospital Georges Pompidou APHP, Paris (France)

12 presentations

1 follower

3 more presentations in this session

Re-evaluating the genetic contribution of monogenic dilated cardiomyopathy

Speaker: Doctor F. Mazzarotto (Florence, IT)

Discovery of the first genome-wide significant risk loci for syncope and collapse

Speaker: Mr G. Ahlberg (Copenhagen, DK)

Loss of Pnn in cardiomyocytes results in impairment of intercalated discs and arrhythmogenic cardiomyopathy in mice

Speaker: Associate Professor S. Leu (Kaohsiung, TW)

Access the full session

What's new in genetics of heart disease

Speakers: Professor J. Hulot, Doctor F. Mazzarotto, Mr G. Ahlberg, Associate Professor S. Leu

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

State of the Art - Drug-gene interaction paving the way to precision medicine

About the speaker

Professor Jean-Sebastien Hulot

3 more presentations in this session

Re-evaluating the genetic contribution of monogenic dilated cardiomyopathy

Discovery of the first genome-wide significant risk loci for syncope and collapse

Loss of Pnn in cardiomyocytes results in impairment of intercalated discs and arrhythmogenic cardiomyopathy in mice

Access the full session

What's new in genetics of heart disease

About the event

ESC Congress 2019

ESC 365 is supported by